Cargando…
Maternal and neonatal outcomes in a treated versus non- treated cohort of women with Gestational Diabetes Mellitus according to the HAPO 5 and 4 criteria
BACKGROUND: Our aim was to evaluate the treatment effect of gestational diabetes mellitus (GDM) according to the Hyperglycemia and Adverse Pregnancy Outcome group (HAPO) screening. RESULTS: The prevalence of GDM, using HAPO 5 was 23.8%. Of these, 72.8% were treated. Comparison of outcomes between tr...
Autores principales: | Maryns, A-S, Dehaene, I, Page, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Universa Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819321/ https://www.ncbi.nlm.nih.gov/pubmed/29479398 |
Ejemplares similares
-
Many HAPO Returns: Maternal Glycemia and Neonatal Adiposity: New Insights from the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) Study
por: Lindsay, Robert S.
Publicado: (2009) -
Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Gestational Diabetes Mellitus and Childhood Glucose Metabolism
por: Lowe, William L., et al.
Publicado: (2019) -
Frequency of Gestational Diabetes Mellitus at Collaborating Centers Based on IADPSG Consensus Panel–Recommended Criteria: The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
por: Sacks, David A., et al.
Publicado: (2012) -
Maternal and Neonatal Outcomes in Pregnant Women with Gestational Diabetes Mellitus Treated with Diet, Metformin or Insulin
por: Simeonova-Krstevska, Slagjana, et al.
Publicado: (2018) -
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: Associations With Neonatal Anthropometrics
Publicado: (2009)